High and Low Molecular Weight Fluorescein Isothiocyanate (FITC)-Dextrans to Assess Blood-Brain Barrier Disruption: Technical Considerations

Translational Stroke Research

Volumn 2, Issue 1, 2011, Pages 106-111

  Hoffmann, Angelika ^a,b   Bredno, Jörg ^c   Wendland, Michael ^b   Derugin, Nikita ^d   Ohara, Peter ^b   Wintermark, Max ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier leakage; FITC dextran; Ischemic stroke; Permeability weighted magnetic resonance imaging

Indexed keywords

EVANS BLUE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; PARAFORMALDEHYDE; SODIUM CHLORIDE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN TISSUE; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DIFFUSION; EXTRAVASATION; FALSE NEGATIVE RESULT; FLUORESCENCE MICROSCOPY; FROZEN SECTION; HISTOPATHOLOGY; IMMOBILIZATION; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

EID: 79951510765     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-010-0049-x     Document Type: Article

References (13)

1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2): 173-85.
2. Dankbaar JW, Hom J, Schneider T, Cheng SC, Lau BC, van der Schaaf I, et al. Age- and anatomy-related values of blood-brain barrier permeability measured by perfusion-CT in non-stroke patients. J Neuroradiol. 2009; 36(4): 219-27.
3. Knight RA, Karki K, Ewing JR, Divine GW, Fenstermacher JD, Patlak CS, et al. Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA. J Cereb Blood Flow Metab. 2009; 29(5): 1048-58.
4. Nag S. Blood-brain barrier permeability using tracers and immunohistochemistry. Meth Mol Med. 2003; 89: 133-44.
5. Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res. 1984; 302(2): 347-55.
6. Nagaraja TN, Keenan KA, Fenstermacher JD, Knight RA. Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood-brain barrier. Microcirculation. 2008; 15(1): 1-14.
7. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1): 84-91.
8. Björn Ingelman AG, Gelin L-E, Eliasson R. Properties and applications of dextrans. Stockholm: Almquist and Wiksell; 1969.
9. Emmrich P, Baumann W, Stechele U. Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants. Eur J Pediatr. 1977; 125(3): 181-90.
10. Wolman M, Klatzo I, Chui E, Wilmes F, Nishimoto K, Fujiwara K, et al. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. 1981; 54(1): 55-61.
11. Thorball N. FITC-dextran tracers in microcirculatory and permeability studies using combined fluorescence stereo microscopy, fluorescence light microscopy and electron microscopy. Histochemistry. 1981; 71(2): 209-33.
12. Budinger E, Laszcz A, Lison H, Scheich H, Ohl FW. Non-sensory cortical and subcortical connections of the primary auditory cortex in Mongolian gerbils: bottom-up and top-down processing of neuronal information via field AI. Brain Res. 2008; 1220: 2-32.
13. Kozler P, Pokorny J. Altered blood-brain barrier permeability and its effect on the distribution of Evans blue and sodium fluorescein in the rat brain applied by intracarotid injection. Physiol Res. 2003; 52(5): 607-14.